Although both FFAR2 and FFAR3 are receptors for SCFAs, only FFAR2 is highly expressed in tumor tissues (Fig. 2A, B) and positively correlated with poor prognosis of lung adenocarcinoma patients (Fig. 2C). This evidence concerns the gene FFAR2 and lung adenocarcinoma.